3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
16
Oropharyngeal Neoplasms
10
Nasopharyngeal Carcinoma
10
Prostatic Neoplasms
7
Laryngeal Neoplasms
6
Rectal Neoplasms
5
Mouth Neoplasms
5
Hypopharyngeal Neoplasms
5
Head and Neck Neoplasms
5
Carcinoma
5
Carcinoma, Non-Small-Cell Lung
4
Esophageal Neoplasms
3
Carcinoma, Squamous Cell
3
Breast Neoplasms
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Salivary Gland Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Nasopharyngeal Neoplasms
2
Mesothelioma
2
Epstein-Barr Virus Infections
2
Carcinoma, Intraductal, Noninfiltrating
2
Astrocytoma
2
Anus Neoplasms
2
Vaginal Neoplasms
1
Urothelial Carcinoma of the Bladder
1
Tongue Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Stomatitis
1
Stomach Neoplasms
1
Interventions
Gemcitabine
9
Cisplatin
9
pembrolizumab
5
durvalumab
3
Specimen Handling
3
Platinum
3
Oxaliplatin
3
Leucovorin
3
1,2-diaminocyclohexaneplatinum II citrate
3
Taxes
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Folfox protocol
2
Fluorouracil
2
Biopsy
2
Albumin-Bound Paclitaxel
2
130-nm albumin-bound paclitaxel
2
zanidatamab
1
trastuzumab deruxtecan
1
peposertib
1
dehydroftorafur
1
binimetinib
1
avelumab
1
Trastuzumab
1
Tegafur
1
S 1 (combination)
1
Radiation Dose Hypofractionation
1
Radiation
1
Paclitaxel
1
Lymph Node Excision
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gallbladder Neoplasms
×
Radiotherapy, Intensity-Modulated
×
90 days
×
Clear all
No trials found.